Investor Information

Inanovate has demonstrated the core benefits of the Bio-ID across an initial selection of key assays. To reach the next major inflection point in the company’s life cycle, Inanovate is presently expanding this demonstration across a series of additional assays of high interest and value to potential customers and partners, and continues to build an operational infrastructure to facilitate product development and the growth of commercial relationships.

Investors interested in learning more about Inanovate’s objectives and associated investment opportunities should contact: [email protected] for further information.